The workgroup has created standard categories for variant classification and has outlined a process for mitigating classification disagreements among labs.
More nucleic acid amplification test usage is ultimately good for patients, hospitals, and the MDx industry, according to a maker of the most widely used assay.
The study will evaluate the ability of VolitionRx's technology to detect prostate cancer and to distinguish different prostate conditions and healthy samples.
A team scrutinized use of the 21-gene recurrence assay with the help of data on more than 70,800 individuals diagnosed with breast cancer between 2005 and 2009.
Management provided an update on reimbursement and new products in the works for whole-genome karyotyping, carrier screening, and oncology.
In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.
Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.
Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.
Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.